WHO ICTRP trial
Clinical Study on rapid-acting insulin analog in intensive basal and bolus…
JPRN-UMIN000010702 · Japan Primary Registries Network (JPRN) · Not Recruiting
Key facts
| Trial ID | JPRN-UMIN000010702 |
|---|---|
| Public title | Clinical Study on rapid-acting insulin analog in intensive basal and bolus insulin therapy ~ Efficacy and safety of glulisine-based multiple daily injection therapy in Japanese diabetic patients |
| Scientific title | Clinical Study on rapid-acting insulin analog in intensive basal and bolus insulin therapy ~ Efficacy and safety of glulisine-based multiple daily injection therapy in Japanese diabetic patients - Clinical Study on rapid-acting insulin analog in intensive basal and bolus insulin therapy ~ Efficacy… |
| Primary sponsor | Sapporo City Generarl Hospital |
| Registry | Japan Primary Registries Network (JPRN) |
| Recruitment status | Not Recruiting |
| Study type | Interventional |
| Phase | Not selected |
| Countries | Japan |
| Conditions | Type 1 and type 2 diabetes mellitus |
| Interventions | Diabetic patients with ≥ HbA1c6.2% who were treated with bolus insulin -Asp, Lisp, was changed to the same unit of Gl along with diet and exercise. Basal insulin dosage is basically not changed. They were observed for 24 weeks with caution… |
| Registration date | May 13, 2013 |
| Target size | 100 |
| Registry page | center6.umin.ac.jp |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: